{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:19:13Z","timestamp":1791389953530,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2019-01-07-00-07-E00046"],"award-info":[{"award-number":["2019-01-07-00-07-E00046"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["20XD1403300"],"award-info":[{"award-number":["20XD1403300"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["2021SYPDRC025"],"award-info":[{"award-number":["2021SYPDRC025"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273510"],"award-info":[{"award-number":["82273510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173405"],"award-info":[{"award-number":["82173405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073429"],"award-info":[{"award-number":["82073429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803120"],"award-info":[{"award-number":["81803120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103712"],"award-info":[{"award-number":["82103712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jid.2024.10.606","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T23:23:21Z","timestamp":1732058601000},"page":"1385-1395.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of ADAM10\/17-Mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9849-0340","authenticated-orcid":false,"given":"Zengyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5545-1676","authenticated-orcid":false,"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-1986","authenticated-orcid":false,"given":"Zeyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-8985","authenticated-orcid":false,"given":"Yifan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9855-767X","authenticated-orcid":false,"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-1713","authenticated-orcid":false,"given":"Chunyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1508-6703","authenticated-orcid":false,"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-7881","authenticated-orcid":false,"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-5918","authenticated-orcid":false,"given":"Yu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.10.606_bib1","article-title":"Evaluation of proteoforms of the transmembrane chemokines CXCL16 and CX3CL1, their receptors, and their processing metalloproteinases ADAM10 and ADAM17 in proliferative diabetic retinopathy","volume":"11","author":"Abu El-Asrar","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib2","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.4049\/jimmunol.1302044","article-title":"In vivo blockade of the programmed cell Death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit","volume":"191","author":"Amancha","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib3","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5114\/ada.2018.75609","article-title":"Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis","volume":"35","author":"Bartosi\u0144ska","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jid.2024.10.606_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jid.2024.10.606_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12949","article-title":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1","volume":"188","author":"Bommarito","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib7","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M112.352534","article-title":"A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome Toxin-1 (TSST-1)","volume":"287","author":"Breshears","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2024.10.606_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the \u201ca disintegrin and metalloproteases\u201d 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2024.10.606_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2024.10.606_bib10","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1073\/pnas.1307478110","article-title":"Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways","volume":"110","author":"Dang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2024.10.606_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/febs.12583","article-title":"T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding","volume":"281","author":"Dewitz","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2024.10.606_bib12","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1074\/jbc.M115.710541","article-title":"Human and murine interleukin 23 receptors are novel substrates for a disintegrin and metalloproteases ADAM10 and ADAM17","volume":"291","author":"Franke","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2024.10.606_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-023-01722-0","article-title":"Gamma Delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment","volume":"22","author":"Gao","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jid.2024.10.606_bib14","doi-asserted-by":"crossref","first-page":"14804","DOI":"10.1074\/jbc.M111.229393","article-title":"Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding","volume":"286","author":"Garbers","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2024.10.606_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.13646","article-title":"CD4+ LAG-3+ T cells are decreased in active psoriatic arthritis patients and their restoration in vitro is mediated by TNF inhibitors","volume":"206","author":"Gertel","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.10.606_bib17","article-title":"LAG3\u2019s enigmatic mechanism of action","volume":"11","author":"Graydon","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.10.606_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/ced.15239","article-title":"The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis","volume":"47","author":"G\u00fcl","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.606_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2024.10.606_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltac016","article-title":"Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors","volume":"2","author":"Jfri","year":"2022","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jid.2024.10.606_bib22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jid.2018.05.021","article-title":"Proportion of CD4+CD49b+LAG-3+ Type 1 regulatory T cells in the blood of psoriasis patients inversely correlates with psoriasis area and severity index","volume":"138","author":"Kim","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.606_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41577-018-0068-5","article-title":"The emerging role of ADAM metalloproteinases in immunity","volume":"18","author":"Lambrecht","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.emboj.7601520","article-title":"Metalloproteases regulate T-cell proliferation and effector function via LAG-3","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2024.10.606_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10753-023-01800-x","article-title":"Long non-coding RNA-GDA-1 promotes keratinocyte proliferation and psoriasis inflammation by regulating the STAT3\/NF-\u03baB signaling pathway via forkhead box M1","volume":"46","author":"Li","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.jid.2024.10.606_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3892\/etm.2015.2876","article-title":"Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis","volume":"11","author":"Li","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jid.2024.10.606_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.10.606_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1744980","article-title":"ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance","volume":"9","author":"Orme","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jid.2024.10.606_bib29","first-page":"73","article-title":"Updated perspectives on keratinocytes and psoriasis: keratinocytes are more than innocent bystanders","volume":"12","author":"Ortiz-Lopez","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.jid.2024.10.606_bib30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2017.07.011","article-title":"Autoimmune aspects of psoriasis: heritability and autoantigens","volume":"16","author":"Prinz","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2024.10.606_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2024.10.606_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jaad.2022.02.030","article-title":"Treatment of immune checkpoint inhibitor-mediated psoriasis: a systematic review","volume":"87","author":"Said","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.10.606_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2024.10.606_bib35","article-title":"Involvement of TNF-\u03b1 converting enzyme in the development of psoriasis-like lesions in a mouse model [published correction appears in PLoS One. 2015;10:e0124989]","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.10.606_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40169-015-0054-5","article-title":"Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites","volume":"4","author":"Swindell","year":"2015","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jid.2024.10.606_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1053\/j.gastro.2014.07.003","article-title":"ADAM10 regulates Notch function in intestinal stem cells of mice","volume":"147","author":"Tsai","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jid.2024.10.606_bib38","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jid.2022.01.014","article-title":"From empirical to pathogenesis-based treatments for psoriasis","volume":"142","author":"van de Kerkhof","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.606_bib39","doi-asserted-by":"crossref","first-page":"31018","DOI":"10.1074\/jbc.M109.006775","article-title":"Metalloprotease ADAM10 is required for Notch1 Site 2 cleavage","volume":"284","author":"van Tetering","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2024.10.606_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbamcr.2012.11.027","article-title":"ADAM17 cleaves CD16b (Fc\u03b3RIIIb) in human neutrophils","volume":"1833","author":"Wang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jid.2024.10.606_bib41","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1074\/jbc.RA119.011192","article-title":"ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface","volume":"295","author":"Yang","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2024.10.606_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107722","article-title":"Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis","volume":"96","author":"Yu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jid.2024.10.606_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41419-018-0482-4","article-title":"FoxM1 drives ADAM17\/EGFR activation loop to promote mesenchymal transition in glioblastoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2024.10.606_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/sji.12404","article-title":"Characterization of Th17 and FoxP3(+) Treg cells in paediatric psoriasis patients","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2024.10.606_bib46","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20150204","article-title":"A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis","volume":"212","author":"Wu","year":"2015","journal-title":"J of Exp Med"},{"key":"10.1016\/j.jid.2024.10.606_bib47","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jid.2022.02.016","article-title":"IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of YAP-AREG axis","volume":"142","author":"Yu","year":"2022","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24029488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24029488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:40:09Z","timestamp":1780278009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24029488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022202X24029488"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.10.606","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ADAM10\/17-Mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.10.606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Investigative Dermatology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}